Cell Care Therapeutics
Blood & Organ Banks · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
750 Royal Oaks Dr Ste 106, Monrovia, Cal...Phone Number
(562) 528-3120Website
www.cell-care.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Cell Care Therapeutics
Cell Care Therapeutics specializes in developing a new class of biologics derived from mesenchymal stromal cells (MSCs) to address blood vessel degeneration and inflammation. Their innovative secretome platform leverages the therapeutic properties of MSCs to promote vascular health. The company is focusing on its lead product candidate, CCT-101, aimed at treating diabetic macular edema, a major cause of vision loss in working age adults. With approximately 120 million individuals affected globally by diabetic retinopathy, Cell Care's solutions target a significant unmet medical need in eye care.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cell Care Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Cell Care Therapeutics launches new products
Cell Care Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Cell Care Therapeutics has new funding data
Check out if Cell Care Therapeutics is spiking on competitors!
Earning: See what the market has to say on Cell Care Therapeutics recently announced quarterly report
Check if Cell Care Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Cell Care Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Cell Care Therapeutics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Cell Care Therapeutics
Compare insights from companies similar to Cell Care Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Cell Care Therapeutics
<$5M
1-10
Private
<$5M
2014
N/A
Company Profile Activity
Activity Insights
Cell Care Therapeutics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Cell Care Therapeutics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Cell Care Therapeutics.
Cell Care Therapeutics financials insights
Gather financial insights about Cell Care Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Angel/Seed
$4.3M
Cell Care Therapeutics Tech Stack
A closer look at the technologies used by Cell Care Therapeutics
Cell Care Therapeutics News & Media
Cell Care Therapeutics Raises $4.3 Million in Seed Funding
MONROVIA, Calif.--(BUSINESS WIRE)--#diabeticretinopathy--Cell Care Therapeutics raises $4.3 million seed funding to develop preclinical-stage drug candidate for the treatment of ocular inflammatory diseases.
Read more news
Top Blood & Organ Banks Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cell Care Therapeutics
Sign Up For FreeTo access detailed company insights
Cell Care Therapeutics specializes in developing a new class of biologics derived from mesenchymal stromal cells (MSCs) to address blood vessel degeneration and inflammation. Their innovative secretome platform leverages the therapeutic properties of MSCs to promote vascular health. The company is focusing on its lead product candidate, CCT-101, ai... Read More
